58 matches for your search in the start-up spotlight
rss
"EG 427 has the potential to significantly advance the applications of genetic medicine through highly targeted delivery and local administration"
04-Mar-2025
EG 427, a biotechnology company leading the development of pinpoint genetic medicines for prevalent chronic diseases in neurology, announced the successful closing of a €27 million Series B financing round co-led by Andera Partners and Bpifrance - as part of the InnoBio investment strategy. “The ...
Cradle raises $73M Series B: Speed up protein research and development by as much as ten times
03-Dec-2024
Cradle, the leading platform for AI-powered protein engineering, has raised $73m in Series B funding to respond to rising demand for its technology in R&D intensive industries. The round was led by IVPwith participation from previous investors Index Ventures and Kindred Capital. With the current ...
Investments will support new product offerings, US expansion, and development of pathology foundation models
05-Nov-2024
Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced that it has raised $34 million in Series B financing. This additional funding will be used to build new product offerings for biopharmaceutical clients, ...
"Lymphatica is addressing a massive unmet medical need..."
15-Oct-2024
Lymphatica Medtech SA, a clinical-stage company based in Lausanne, Switzerland, specialized in innovative treatments for lymphedema, has raised €17.9 million in Series B funding. This investment will accelerate the clinical development and validation of LymphoDrain, a breakthrough implantable ...
One of the largest private Italian Biotech company financings to date
01-Oct-2024
Genespire, a biotechnology company developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases, announced the closing of a €46.6 million (~$52 million) Series B financing, co-led by Sofinnova Partners, XGEN Venture and CDP Venture Capital through its Large Venture ...
Funding will support and accelerate development of next-generation multivalent respiratory virus vaccines
30-Sep-2024
Vicebio Ltd, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, announces a $100 million Series B financing led by TCGX with investment from Goldman Sachs Alternatives, Avoro Ventures, venBio, and participation from UniQuest and founding ...
16-Sep-2024
PhoreMost Ltd. announced it has added USD $12 million to its Series B financing, bringing the total raised to over $50 million. The additional investment was led by Parkwalk Advisors, the largest growth EIS fund manager, with participation from existing investors BGF, Dr Jonathan Milner, Amadeus ...
With the new funding, Qualifyze aims to expand its operations into the US market
13-Sep-2024
Qualifyze announced $54 million in Series B funding from global software investorInsight Partners, with participation from existing investorsHV Capital,HarbourVest Partners,H14 andCherry Ventures. With the new funding, Qualifyze aims to expand its operations into the US market, continue investing ...
Fighting plastic pollution and GHG emissions
11-Sep-2024
Calyxia, an industrial B2B Cleantech innovator, certified B Corp, specializing in advanced and biodegradable microcapsules and microparticles for use in Consumer Goods, Crop Protection and Advanced Materials, announced that it has raised $35 million in a Series B funding round. The round was led ...
Proceeds to support Phase 1 clinical trials for two proprietary programs, and to advance two additional programs to IND approval
06-Aug-2024
Confo Therapeutics announced the closing of a EUR 60M Series B financing. The round was led by Ackermans & van Haaren (AvH) and included participation from additional new investors, Driehaus Capital Management and Quest for Growth (QfG), as well as existing investors, BioGeneration Ventures ...
